‘Beijing is offering loans and priority access to developing countries for vaccinations as they move to large-scale trials. As richer nations scramble for early doses manufacturing constraints likely to cause shortages for years...
‘Vaccines being developed in China are among front-runners in the hunt for safe and effective immunisations to counter the pandemic. China’s diplomats are saying, if successful, the vaccines will be a “global public good”, a pledge made by President Xi Jinping at a meeting of the World Health Organisation’s governing body in May. The assurances come as multiple vaccines worldwide move into large-scale late-phase trials, a step away from potential approval. However, supply shortages for any approved products are likely to persist for months or even years due to manufacturing constraints.’
Read here (South China Morning Post, August 4, 2020)
